Retinal perivascular amyloid imaging in relationship to MRI neuroimaging abnormalities and cognitive impairment
Abstract Background Scanning laser ophthalmoscopy (SLO) visualizes two important markers of cognitive dysfunction in the retina: vascular changes and amyloid plaque (AP) deposition. The relationship between retinal arteriolar versus venular changes and perivascular amyloid deposition across the continuum of neurodegeneration is imperfectly understood. We investigate the retinal perivascular AP distribution in relationship to cognitive and neuroimaging measures in a cohort of cognitively normal and impaired individuals. Method 34 subjects with normal or impaired cognition underwent retinal SLO, brain magnetic resonance imaging and standard neuropsychometric testing. Retinal peri‐arteriolar and peri‐venular curcumin positive AP were quantified in the supero‐temporal retinal quadrant, in the first, second and third‐order retinal vascular branches. The peri‐venular and peri‐arteriolar AP count were compared between patients with normal and impaired cognition, and their correlation with brain volumes, white matter hyperintensities and cognitive Z‐scores was determined. Result We analyzed retinal para‐venous and para‐arteriolar amyloid count in 28 subjects, mean (SD) age 65 (7.3), 50% female, 19 (52.6%) with impaired cognition. Para‐arteriolar plaque count was higher than peri‐venular plaque in the entire cohort (p<0.0001). Secondary branch peri‐venular amyloid plaque count was higher in patients with MOCA ≤26. Tertiary branch perivascular AP count significantly and negatively correlated with hippocampal volume and positively correlated white matter hyperintensity lesion count. Conclusion Retinal AP deposit peri‐arteriolarly overall and peri‐venularly in the secondary branches in cognitively impaired. Perivascular amyloid burden in small retinal branches correlates with hippocampal volume and white matter hyperintensities.
Authors
- Keith L. Black (ORCID: https://orcid.org/0000-0002-0546-4934)
- Julie A. Schneider (ORCID: https://orcid.org/0000-0002-9482-1752)
- Ken Johnson (ORCID: https://orcid.org/0000-0001-5442-4392)
- Steven Verdooner
- Jonah Doustar (ORCID: https://orcid.org/0000-0002-3029-0067)
- Dieu‐Trang Fuchs
- Maya Koronyo‐Hamaoui (ORCID: https://orcid.org/0000-0003-2864-8442)
- Patrick D. Lyden (ORCID: https://orcid.org/0000-0001-6170-4042)
- Dale Sherman
- Roxana O. Carare (ORCID: https://orcid.org/0000-0002-4408-8636)
- Oana M. Dumitrascu (ORCID: https://orcid.org/0000-0003-2033-449X)
- Michelle Miller (ORCID: https://orcid.org/0000-0001-7114-3517)
- Yosef Koronyo
Institutions
- Tulane University (US)
- University of Southern California (US)
- Cedars-Sinai Medical Center (US)
- Rush University Medical Center (US)
- Mayo Clinic in Arizona (US)
- NVision Eye Centers (United States) (US)
- University of Southampton (GB)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.090891
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00